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This study aimed to assess the association between oxidative damage markers and carotid
artery intima-media thickness (CIMT) after controlling for conventional risk factors of athero-
sclerosis in multiple logistic regression models.
Methods and Findings
Fifty-one case male participants (CIMT 0.9 mm) were enrolled during their visits to Korean
Genomic Rural Cohort Study of Wonju centers between May 1 and August 31, 2011, along
with 51 control participants (CIMT< 0.9 mm) selected using frequency matching by age
group. The levels of oxidative damage markers, 8-hydroxy-20-deoxyquuanosine (8-OHdG),
malondialdehyde (MDA), and 8-iso-prostaglandin F2α (Isoprostane), were measured. Con-
ditional logistic regression models were used to evaluate relative relationships between the
oxidative damage markers and the risk of high CIMT.
Results
The markers of oxidative lipid (Isoprostane and MDA) and DNA (8-OHdG) damage were as-
sociated with CIMT after controlling for the conventional risk factors, including age, low den-
sity lipoprotein, body mass index, smoking history, alcohol consumption, and metabolic
syndrome (ORs [95% CI] for Isoprostane: 3rd tertile, 8.47 [2.59-27.67]; for MDA: 3rd tertile,
8.47 [2.59-27.67]; for 8-OHdG: 3rd tertile, 5.58 [1.79-17.33]). When all the oxidative damage
markers were incorporated in the same logistic regression model, only Isoprostanewas sig-
nificantly related to CIMT (OR [95% CI]: 4.22 [1.31-13.53] in 2nd tertile and 14.21 [3.34-
60.56] in 3rd tertile).
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Conclusions
In this nested case-control study, the oxidative damage markers of lipid and DNA were as-
sociated with CIMT even after controlling for the conventional risk factors of
cardiovascular diseases.
Introduction
Atherosclerosis and endothelial dysfunction are considered underlying mechanisms of cardio-
vascular disease [1]. Numerous studies examining the complex pathophysiological mecha-
nisms associated with cardiovascular disease have revealed a critical role of oxidative stress in
the development of atherosclerosis [2].
Oxidative stress is caused by overproduction of reactive oxygen species (ROS) and free radi-
cals beyond the physiological detoxifying capacity of the cells or their ability to repair the re-
sulting damage [3]. Although ROS and free radicals are essential elements of biological
systems, such as cell signaling, controlling vascular tone, and generation and degeneration of
target cells [4], their high chemical reactivity causes oxidative damage of lipids, DNA, and pro-
teins. However, the direct measurement of free radicals and ROS using electron resonance or
spin trapping is very technically challenging and expensive in humans [5]. Therefore, simpler
methods that examine the end products of oxidative damage are used to evaluate oxidative
stress. For example, 8-hydroxy-20-deoxyguanosine (8-OHdG) is a marker of damaged DNA
[6], whereas malondialdehyde (MDA) and 8-iso-prostaglandin F2α (Isoprostane) are markers
of lipid peroxidation damage [4,7]. These forms of oxidative damage are considered key patho-
logic mechanisms underlying cardiovascular disease [8].
Although there is pathophysiologic evidence indicating that oxidative damage markers are
linked to the risk of atherosclerosis [8], human studies utilizing multivariate analysis to control
for conventional atherosclerosis risk factors, such as obesity, blood pressure, insulin resistance,
lipid profile, smoking history, and alcohol consumption, are relatively rare and controversial
[9]. In particular, it has been suggested that there is no independent association between oxida-
tive stress and coronary artery disease when the conventional cardiovascular risk factors are ac-
counted for in statistical models [10]. To resolve this controversy, in the present study we
conducted multivariate analyses to investigate the relationship between the oxidative damage
markers and the carotid artery intima-media thickness (CIMT) after controlling for the con-
ventional risk factors of atherosclerosis. The results provide new insights into the roles of indi-
vidual DNA and lipid oxidative damage markers in atherosclerosis.
Materials and Methods
Ethics Statement
The current study was nested within the Korean Genomic Rural Cohort Study (KGRC). All
participants provided written informed consent for their participation. This study was ap-
proved by the Institutional Review Board of Wonju Christian Hospital.
Study subjects
Male participants were enrolled during their visits to Korean Genomic Rural Cohort Study of
Wonju centers between May 1 and August 31, 2011. A medical history questionnaire was used
to screen for the exclusion criteria among a total of 214 individuals who visited the cohort
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centers. We excluded 40 individuals who had a cardiovascular event, e.g., angina, myocardial
infarction, and stroke, or a medical history of chronic hepatitis, osteoporosis, kidney disease,
asthma, or any malignant disease. Using a CIMT cut-off level of 0.9 mm [11,12], 51 case partic-
ipants (CIMT 0.9 mm) and 51 control participants (CIMT< 0.9 mm) were sampled at ran-
dom using frequency matching by age group (41–50, 51–60, 61–70, and 71–80 years).
Measurement of anthropometrics, metabolic characteristics, and
oxidative damage markers
Comprehensive questionnaires were administered and physical examinations were performed
according to standard procedures [13]. A history of regular alcohol consumption was recorded.
The subjects were categorized according to their smoking status (current smoker, ex-smoker,
and never smoked), and that status was categorized into never vs. ever smoker. The following
parameters were obtained from a self-reported questionnaire: medical history of cardiovascular
events, e.g., angina, myocardial infarction, and stroke; medical history of chronic hepatitis, os-
teoporosis, kidney disease, asthma, or any malignant disease; and pharmacological treatment
of hypertension (HTN), diabetes mellitus (DM), and dyslipidemia.
Body weight, height, and waist circumference were measured while wearing indoor clothing
without shoes. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were mea-
sured twice from the right arm using a standard mercury sphygmomanometer (Bauman-
ometer; USA). Mean SBP and DBP levels were used for data analysis. Venous blood samples
were drawn in the morning after overnight fasting and stored at -80°C. Fasting blood glucose
(FBG) and insulin (FBI) levels were determined by a glucose oxidase-based assay and double-
antibody radioimmunoassay (RIA). The serum concentrations of low-density lipoprotein cho-
lesterol (LDL), high-density lipoprotein cholesterol (HDL), and triglycerides were determined
by enzymatic methods (ADVIA 1650; Bayer, USA). All urine samples were collected in ultravi-
olet-safe urine tube, and were stored at -80°C. The urine samples were clean-up by solid phase
extraction with methanol, phosphate butter before analysis. The concentrations of 8-OHdG,
Isoprostane, and MDA were measured in spot urine samples using a high-performance-liquid
chromatography-triple tandem mass spectrometer (HPLC-MS/MS, Agilent 6410; Agilent).
The urinary levels of all oxidative stress damage markers were corrected according to urine cre-
atinine values. The level of urine creatinine was measured by Jaff reaction. The method detec-
tion limits and relative standard deviations for accuracy and repeatability, respectively, were
0.053 μg/L and 1.29%/0.90% for 8-OHdG, 0.162 pg/mL and 1.29%/2.10% for Isoprostane, and
0.044 μmol/L and 5.36%/2.10% for MDA. Glomerular filtration rate was calculated by using
modification of diet in renal diseases formula [14].
Ultrasound imaging analysis
Bilateral carotid intima-media thickness (CIMT) on both sides was measured on longitudinal
2-dimentional ultrasonography images recorded with a B-mode ultrasound system (Vivid 7;
General Electric Vingmed) with a 12-MHz transducer. Still images of the region near the carot-
id bifurcation were digitally acquired, and the far walls of the carotid artery were displayed as 2
bright lines separated by a hypoechoic space. CIMT between the leading edge of the first bright
line (lumen-intima interface) and the leading edge of the second bright line (media-adventitia
interface) was obtained using semi-automated edge-detection software. The values of CIMT
exceeding 2 cm were measured within 1 cm from the carotid bulb. The mean maximum value
of CIMT on both sides was chosen as the indicator of subclinical atherosclerosis [15].
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Statistical Analysis
Data were expressed as frequencies (%), mean values with standard deviations, and median val-
ues with low and high quartiles. The distribution of continuous variables was examined for
skewness and kurtosis and triglyceride was logarithmically transformed. We used the t-test,
Mann-Whitney U test, or chi-square test to compare the differences between the case and con-
trol groups. Multiple conditional logistic regression models were tested for the ORs of oxidative
damage markers with an adjustment for conventional risk factors, e.g., LDL, body mass index
(BMI), smoking history, alcohol consumption, SBP, FBG, chronic kidney diseases and pharma-
cological treatment of HTN, DM and dyslipidemia. The tertile (T) increment of Isoprostane,
8-OHdG, and MDA was used as an independent variable (Isoprostane [ng/mg creatinine]: 1st
T,<0.21; 2nd T, 0.21–0.51; 3rd T,0.51; 8-OHdG [μg/g creatinine]: 1st T,<0.66; 2nd T, 0.66–
1.25; 3rd T,1.26; MDA [μmol/g creatinine]: 1st T,<0.10; 2nd T, 0.10–0.20; 3rd T,0.20). Sta-
tistical significance was determined at P< 0.05 for all comparisons in the current study.
Results
Anthropometric and metabolic characteristics of the case and control
groups
We used frequency matching according to the age distribution in the case group (Table 1). The
smoking history and pharmacological treatment of HTN, DM, and dyslipidemia were similar
for the 51 case participants and 51 controls. Various metabolic biomarkers, such as triglycer-
ides, FBG, FBI, SBP, and DBP were also similar between the case and control groups. The
serum level of LDL was higher in the case group than in the control group. The levels of all the
oxidative damage markers were significantly higher in the case group than in the control group
(median values of case vs. control groups, respectively: Isoprostane, 0.50 vs. 0.21, P< 0.0001;
8-OHdG, 1.26 vs. 0.74, P = 0.0021; MDA, 0.20 vs. 0.11, P = 0.0005).
The relationship between the oxidative damage markers and CIMT after
controlling for the conventional risk factors of atherosclerosis in multiple
logistic regression models (Table 2)
Compared with the 1st tertile of Isoprostane and MDA values, the 2nd and 3rd tertiles of these
oxidative damage markers were associated with an increased risk of high CIMT in model I
(ORs [95% CI] for Isoprostane: 2nd tertile, 3.80[1.36–10.59]; 3rd tertile, 7.30[2.50–21.29]; for
MDA: 2nd tertile, 3.08[1.13–8.42], 3rd tertile, 6.39[2.24–18.25]). The 3rd tertile of the 8-OHdG
values was a high risk factor compared with the 1st tertile (ORs [95% CI] for 8-OHdG: 2nd ter-
tile, 1.34[0.48–3.78], 3rd tertile, 5.43[1.86–15.84]). These associations were not attenuated after
the adjustment for age, smoking history, regular alcohol consumption, SBP, FBG, LDL, eGFR
and pharmacological treatment of HTN, DM or dyslipidemia in model II [ORs (95% CI) for
Isoprostane: 2nd tertile, 4.22 (1.31–15.53); 3rd tertile, 14.21 (3.34–60.56); CI] for MDA: 2nd ter-
tile, 4.22 (1.27–13.99), 3rd tertile, 6.46 (1.91–21.83); for 8-OHdG: 2nd tertile, 0.77 (0.22–2.64),
3rd tertile, 4.45 (1.27–15.56)]. All p values for trend according to increment of ORs were below
0.01.
The relationships between the oxidative damage markers and the risk of
atherosclerosis (Table 3)
Multiple logistic regression models were constructed with covariates age, smoking history, reg-
ular alcohol consumption, SBP, FBG, LDL, eGFR and pharmacological treatment of HTN, DM
or dyslipidemia. Two oxidative damage markers were incorporated into the same model. The
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ORs (95% CI) of the 3rd tertile were 16.61 (3.44–80.15) for Isoprostane and 4.25 (1.05–17.16)
for 8-OHdG in model A, 4.74 (1.33–16.94) for MDA and 3.16 (0.83–12.10) for 8-OHdG in
model B, and 9.84 (2.12–45.70) for Isoprostane and 3.59 (0.94–13.64) for MDA in model C.
When all the 3 oxidative damage markers were incorporated into the same multiple logistic re-
gression model, MDA and 8-OHdG lost its significant association with CIMT. However, the
associations with CIMT were still significant for Isoprostane (OR [95% CI]: 4.22 [1.31–13.53]
in 2nd tertile and 14.21 [3.34–60.56] in 3rd tertile).
Discussion
In this nested case-control study, increased levels of the oxidative damage markers were associ-
ated with the CIMT. Importantly, the associations between the oxidative damage markers and
CIMT were still significant after controlling for the conventional risk factors, such as age,
smoking history, regular alcohol consumption, SBP, FBG, LDL, eGFR and pharmacological
treatment of HTN, DM or dyslipidemia. Furthermore, lipid peroxidation damage marker,
Table 1. Demographic andmetabolic characteristics of the case and control groups.
Cases (n = 51)CIMT
0.9 mm
Controls (n = 51)
CIMT < 0.9 mm
P value
Demographic characteristics
Age, n (%) 1.000
40~50 2 (3.92) 2 (3.92)
51~60 14 (27.45) 14 (27.45)
61~70 29 (56.86) 29 (56.86)
71~80 6 (11.76) 6 (11.76)
Pharmacologic treatments, n (%)
Hypertension 18 (35.29) 20 (39.22) 0.6821
Diabetes 6 (11.76) 5 (9.08) 0.7496
Dyslipidemia 6 (11.76) 9 (17.65) 0.4016
% of never smoker, n (%) 19 (37.25) 24 (47.06) 0.4239
% of alcohol drinker, n (%) 34 (66.67) 35 (68.63) 0.8324
Metabolic characteristics
Isoprostane / creatinine ratio 0.50 (0.27–0.80) 0.21 (0.15–0.47) <.0001
8-OHdG / creatinine ratio 1.26 (0.69–1.83) 0.74 (0.45–1.14) 0.0021
MDA / creatinine ratio 0.20 (0.13–0.28) 0.11 (0.08–0.16) 0.0005
Triglyceride (mg/dL) 133.00 (97–177) 128.00 (84–159) 0.2955
Body mass index (kg/m2) 23.98 ±2.73 24.20 ±2.93 0.6935
Waist circumference (cm) 85.25 ±5.78 86.11 ±7.71 0.5289
Fasting plasma glucose (mg/dL) 104.92 ±24.73 98.75 ±14.23 0.1290
Systolic blood pressure (mmHg) 127.48 ±14.55 126.88 ±14.92 0.8390
Diastolic blood pressure (mmHg) 76.94 ±11.72 80.59 ±9.55 0.0893
LDL (mg/dL) 117.58 ±25.94 106.02 ±31.07 0.0453
HDL (mg/dL) 50.02 ±9.89 51.65 ±12.44 0.4692
MetS proportion (n, %) 17 (33.30) 18 (35.29) 0.8348
eGFR (mL/min/1.73 m2) 79.34 x12.55 76.97 ±11.28 0.3163
Abbreviations: CIMT, carotid intima media thickness; BMI, body mass index; Isoprostane, 8-iso-prostaglandin F2α; 8-OHdG, 8-hydroxy-2'-
deoxyguanosine; MDA, malondialdehyde; MetS, metabolic syndrome; LDL, low density lipoprotein; HDL, high density lipoprotein; eGFR, estimated
glomerular ﬁltration rate.
doi:10.1371/journal.pone.0119731.t001
Oxidative DamageMarkers and Atherosclerosis
PLOS ONE | DOI:10.1371/journal.pone.0119731 March 25, 2015 5 / 10
Isoprostane, was independent from other oxidative damage markers when incorporated into
one multiple logistic regression model to estimate the risk of atherosclerosis.
According to the oxidative modification hypothesis of atherosclerosis, the native state of
LDL is not atherogenic [16]. However, entrapping of LDL in the sub-endothelial space leads to
alteration of its surface net charge as a result of oxidative modification, which stimulates mono-
cyte chemotaxis and inflammation [17]. Oxidized LDL is susceptible to uptake via the
Table 2. Relationship between oxidative damagemarker and carotid artery intimamedia thickness (mm).
Model I Model II
OR (95% CI) OR (95% CI)
Isoprostane,ng/mg creatinine OR (95% CI) 1st tertile (<0.21) 1.00 - 1.00 -
2nd tertile (<0.51) 3.80 (1.36–10.59) 4.221 (1.31–13.53)
3rd tertile (0.51) 7.30 (2.50–21.29) 14.21 (3.34–60.56)
P for trend <0.001 <0.001
MDA,μmol/g creatinine OR (95% CI) 1st tertile (<0.10) 1.00 - 1.00 -
2nd tertile (<0.20) 3.08 (1.13–8.42) 4.22 (1.27–13.99)
3rd tertile (0.20) 6.39 (2.24–18.25) 6.46 (1.91–21.83)
P for trend 0.001 0.002
8-OHdG,μg/g creatinine OR (95% CI) 1st tertile (<0.66) 1.00 - 1.00 -
2nd tertile (<1.26) 1.34 (0.48–3.78) 0.77 (0.22–2.64)
3rd tertile (1.26) 5.43 (1.86–15.84) 4.45(1.27–15.56)
P for trend 0.002 0.020
ORs were calculated at level of carotid intima media thickness > 10 mm.
P for trend were calculated by conditional logistic regression models.
Abbreviations: Isoprostane, 8-iso-prostaglandin F2α; 8-OHdG, 8-hydroxy-2'-deoxyguanosine; MDA, malondialdehyde; OR (95% CI), odds ratio (95%
conﬁdence interval), OR (95% CI): odds ratio (95% conﬁdence interval).
Model I: not adjusted
Model II: adjusted for age, smoking history, regular alcohol consumptions, systolic blood pressure, fasting blood glucose, low density lipoprotein,
glomerular ﬁltration rate and pharmacological treatment of hypertension, diabetes and dyslipidemia.
doi:10.1371/journal.pone.0119731.t002
Table 3. Independent relationship among oxidative damagemarkers to carotid intimamedia thickness.
Model A Model B Model C Model D
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Isoprostane,ng/mg creatinine 1st tertile (<0.21) 1.00 - 1.00 - 1.00 -
2nd tertile (<0.51) 4.72 (1.37–16.20) 3.37 (0.98–11.63) 3.93 (1.08–14.25)
3rd tertile (0.51) 16.61 (3.44–80.15) 9.84 (2.12–45.70) 11.73 (2.30–59.74)
MDA,μmol/g creatinine 1st tertile (<0.10) 1.00 - 1.00 - 1.00 -
2nd tertile (<0.20) 2.83 (0.80–10.06) 3.93 (1.15–13.45) 2.47 (0.66–9.20)
3rd tertile (0.20) 4.74 (1.33–16.94) 3.59 (0.94–13.64) 2.38 (0.55–10.23)
8-OHdG,μg/g creatinine 1st tertile (<0.66) 1.00 - 1.00 - 1.00 -
2nd tertile (<1.26) 0.58 (0.15–2.30) 0.81 (0.21–3.10) 0.77 (0.18–3.34)
3rd tertile (1.26) 4.25 (1.05–17.16) 3.16 (0.83–12.10) 4.04 (0.94–17.50)
All models were adjusted for age, body mass index, smoking history, regular alcohol consumptions, systolic blood pressure, fasting plasma glucose, low
density lipoprotein, glomerular ﬁltration rate and pharmacological treatment of hypertension, diabetes and dyslipidemia
Abbreviations: Isoprostane, 8-iso-prostaglandin F2α; 8-OHdG, 8-hydroxy-2'-deoxyguanosine; MDA, malondialdehyde; OR (95% CI), odds ratio (95%
conﬁdence interval), OR (95% CI): odds ratio (95% conﬁdence interval).
doi:10.1371/journal.pone.0119731.t003
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macrophage scavenger system, and this incorporation and accumulation in macrophages is a
major cause of foam cell transformation and plaque formation [18]. Thus, free radical-initiated
lipid peroxidation is a key mechanism of the development of atherosclerosis and inflammatory
vascular damage. Based on these considerations, it can be expected that the association between
oxidative damage markers and atherosclerosis is independent of the total blood level of LDL.
Indeed, in the current study, the associations between the oxidative damage markers and the
risk of atherosclerosis were still significant after controlling for conventional cardiovascular
risk factors, such as age, smoking history, regular alcohol consumption, SBP, FBG, LDL, eGFR
and pharmacological treatment of HTN, DM or dyslipidemia.
Isoprostane, the stable isomer of prostaglandin F2α, is formed non-enzymatically by a free
radical attack on arachidonic acid, a lipid component of the cell membrane. Some studies com-
pared the daily variation in the levels of Isoprostane in spot urine and 24-h urine samples, and
observed no significant differences throughout the day in either samples [19]. In agreement
with this, the mean levels of Isoprostane in morning urine samples were not significantly differ-
ent from those in 24-h collection samples [20]. Therefore, the level of Isoprostane in the urine
is widely used as the gold standard marker of lipid peroxidation [21]. We measured this level
with HPLC-MS/MS, which has been reported to be one of the most reliable methods [22]. Sev-
eral pathogenesis of cardiovascular are linked to Isoprostane excretion and formation. The
pathogenic roles of Isoprostane on cardiovascular diseases were also proposed as vasoconstric-
tion, platelet aggregation, angiogenesis and monocyte adhesion [23]. MDA is produced during
the oxidative attack on lipoproteins and polyunsaturated fatty acids. Hence, MDA is one of the
lipid peroxidation markers. However, these two lipid peroxidation markers (MDA and Iso-
prostane) were not independent of each other when estimating the risk of atherosclerosis in the
same multiple logistic regression model (Table 3, model C). Furthermore, the Isoprostane
more strongly related to CIMT compare to MDA did in model D, which incorporated all oxi-
dative damage marker (Table 3).
Oxidative hydroxylation in the 8th position of deoxyguanosine, which results in formation
of 8-OHdG, is a common mutagenic DNA lesion [24]. Elevated levels of 8-OHdG are associat-
ed with various malignant conditions [25] and their prognoses [26]. Apoptosis, or pro-
grammed cell death, is induced by DNA damage, and endothelial cell death is an early event of
atherogenesis that triggers plaque formation [27]. Apoptosis of vascular smooth muscle cells
(VSMCs) is associated with the growth of plaques as a result of outward remodeling [28].
Moreover, it triggers intense intimal inflammation [29], which induces foam cell formation via
the accumulation of lymphocytes. Formation of atherogenic lesions may be initiated in VSMC
by mutational events, such as tumor cell growth after DNA damage [30]. Therefore, 8-OHdG
is associated with atherosclerosis and plaque formation [24]. In the current study, the associa-
tion between 8-OHdG and CIMT was significant after controlling for the lipid peroxidation
markers (Isoprostane). That result suggested that this DNA damage marker has a somewhat
different pathophysiological role. Xiang et al. [31] show increment of 8-OHdG related to num-
ber of coronary artery disease vessels. Hence, increment of 8-OHdG might predict the severity
of cardiovascular diseases. Furthermore, that relationship was still significant after adjustment
of age, sex, smoking hypertension, dyslipidemia, DM [31]. In the same context, our current
study show the 8-OHdG were independently associated with the subclinical atherosclerosis in
multivariable analysis including age, smoking history, regular alcohol consumption, SBP, FBG,
LDL, eGFR and pharmacological treatment of HTN, DM or dyslipidemia.
Recently, Isoprostane also used to investigate the association between air pollutants expo-
sure and oxidative modifications of lipoproteins. The lipid peroxidation detected by Isopros-
tane level was suggested as one of the key mechanism regarding to effect of air pollution on
vascular diseases [32]. The complex combination of lipid peroxidation markers closely related
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to change of nano-plaque formation or size [33]. Hence, that clinical intervention study sug-
gested that markers of lipid peroxidation might serve for monitoring of early diseases progress
[33].
Several limitations were considered when interpreting the current results. The main limita-
tion was the cross-sectional nature of our case-control study design, which prevents elucidation
of cause-effect relationships. Furthermore, atherosclerotic lesions themselves produce oxidative
stress, and this vicious circle contributes to the elevation of oxidative damage markers [17]. To
minimize this effect, we excluded individuals who had a cardiovascular event, chronic hepatitis,
osteoporosis, kidney disease, asthma, or any malignant disease, but we could not exclude pa-
tients with HTN, DM, and dyslipidemia. For example, glycemic disorders induce oxidative
stress, and a chronic hyperglycemic status, such as in DM, is deeply associated with endothelial
dysfunction, i.e., vascular disease [34]. Measuring of serum glucose level was only sampled
after overnight fasting. Hence we have no data of post-prandial hyperglycemia or oral glucose
tolerance test which status may induce oxidative stress. Furthermore we had no information
on clinical severity and duration of DM, HTN and dyslipidemia, and family history of cardio-
vascular events which related to atherosclerosis events. Although the autoimmune diseases are
related to oxidative stress and vascular damage, we cannot exclude that patient in current
study. Therefore, to draw more firm conclusion about our aim of study, a more comprehensive
and prospective cohort study is warranted to elucidate the causal relationship between oxida-
tive stress and atherosclerosis. Furthermore, we have no information regarding the consump-
tion of dietary vitamin supplements in our cohort, which could also reduce the levels of
oxidative damage markers [35].
Finally, the relatively small sample size and the fact that the participants were from the same
geographic area may limit the applicability of our results to the determination of the atheroscle-
rosis risk in general population. Furthermore, because we used only male participant in current
study, our results cannot be generalized to female population.
In summary, higher levels of the oxidative damage markers were correlated with CIMT.
These associations remained significant after the adjustment for other conventional risk fac-
tors, such as LDL, BMI, smoking history, alcohol consumption, and MetS. Furthermore, the
lipid peroxidation marker (Isoprostane) and the DNA damage marker (8-OHdG) were inde-
pendent of each other when incorporated into the same multiple logistic regression model to
estimate the risk of atherosclerosis.
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